Seeman

1. Bilezikian buy generic lasix

 JP. Osteoporosis in men. J Clin Endokrinol Metab. 1999 84:34314. 2. E. Seeman

 osteoporosis in men. Osteoporos Int. 1999 (9 Supplement 2): S97S110. 3. Orwoll

 ES. Osteoporosis in men. Endokrinol Metab Clin North Am. 1998, 27:34967. 4. Cooper

�

 From Campion G,

 Melton LJ

  3. Hip fractures in elderly people: worldwide projection. Osteoporos Int. 1992; 2:2859. 5. Gilsanz V. accumulation of bone mass in childhood and adolescence. In: Orwoll ES, ed. Osteoporosis in men. San - Diego, CA: Academic, 1999:6585. 6. Klibanski, Campbell-Adams L, T Bassford, Blair SN, Boden SD, Dickersin K, et al. NIH consensus development conference statement: osteoporosis prevention, diagnosis and therapy. 2729 in March 2000. Access 11 December 2002 at the following address: WWW. consensus. NIH. gov/cons/111/111_statement. HTM. 7. Amin

 S,

 Felson DT. Osteoporosis in men. Rheum Dis Clin North Am. 2001, 27:1947. 8. Beck TJ

 ,

 Ruff CBR, Scott

  WW-junior, Plato

 CC,

Tobin JD

 ,

 Quan CA. Sex differences in the geometry of the femoral neck with aging: a structural analysis of bone mineral data. Calcif tissue Int. 1992, 50:249. 9. Looker AC

 ,

 Orwoll ES, Johnston

  CC-junior, Lindsay

 RL,

Wahner HW

 ,

 Dunn WL,

al. Prevalence of low femoral bone density in elderly men from the U.S. NHANES III. In Costa Miner Res. 1997, 12:17618. 10. With Cooper

�

 Melton LJ

 3. Epidemiology of osteoporosis. Trends Endokrinol Metab. 1992; 3:2249. 11. Forsen

 L,

 Sogaard AJ,

 Meyer HE, Edna T

�

 Kopjar B. Survival after hip fracture: short-and long-term excess mortality according to age and sex. Osteoporos Int. 1999; 10:738. 12. Poor

 G,

 Atkinson EJ,

 O'Fallon WM,

 Melton JL

 3. Determinants of decrease survival of patients after hip fracture in men. Clin Orthop. 1995, 319:2605. 13. Sernbo I

 ,

 Johnell O. Consequences of hip fracture: prospective study over 1 year. Osteoporos Int. 1993, 3:14853. 14. Jensen

 JS,

 Bagger J. Long-term social prognosis after hip fracture. Acta Orthop Scand. 1982 53:97101. 15Kelepouris

 N, Harper

 KD, Hennon

 F, Kaplan

 FS,

 Haddad JG. Severe osteoporosis in men. Ann internal Med. 1995, 123:45260. 16. Harper

 KD,

 Weber TJ. Secondary osteoporosis: diagnostic considerations. Endokrinol Metab Clin North Am. 1998, 27:32548. 17. E Seeman

�

 Melton LJ

  3D,

 O'Fallon WM,

 Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med. 1983 75:97783. 18. Recommendations for prevention and treatment of osteoporosis caused by glucocorticoids. 2001 Update, American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis. Arthritis rhubarb. 2001; 44:1496503. 19. Orwoll

 ES,

 Klein RF. Osteoporosis in men. Endocr Rev. 1995; 16:87116. 20. Finkelstein

 JS,

 Klibanski,

 Neer RM,

 Doppelt SH,

 Rosenthal DI, Segre GV

 ,

al . Increased bone density in the treatment of men with idiopathic hypogonadotrophic hypogonadism. J Clin Endokrinol Metab. 1989 69:77683. 21. Amin

 S, Zhang

 Y, Savvino

�

 CT Evans SR, Hannan >> << MT,

 Kiel DP,

 al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men with research Framingham. Ann internal Med. 2000, 133:95163. 22. Riggs BL

Hosla S, Melton

 ,

�

LJ 3D. Unitary model for aging osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in older men. In Costa Miner Res. 1998, 13:76373. 23. GA Greendale

  ,

 Edelshteyn S,

 BarrettConnor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. In Costa Miner Res. 1997, 12:183343. 24. Anderson FH, Cooper C hip and spine fractures in: Orwoll ES yet osteoporosis in men, San Diego, CA: Academic 1999: 2949. 25. Klein RF Alcohol in: Orwoll ES, ed. Osteoporosis in men, San Diego, CA: Academic, 1999:43761. 26. Orwoll

 E. Evaluation of bone density in men. In Costa Miner Res. 15:186770 2000. 27. Bonnick SL bone densitometry in clinical practice: application and interpretation of Totowa, NJ: Humana, 1998. 28. E Orwoll

�

�

 Oettinger M Weiss S, Miller

�

 Kendler D,

 Graham J,

 al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000, 343:60410. 29. Vollach

S,

 Cohen S,

 Reid DM,

�

 Hughes RA Hoskynh DJ,

�

 RF Laan et al. Effects ryzedronat treatment on bone density and fractures of the spine in patients on therapy with corticosteroids. Calcif tissue Int. 2000 67:27785. 30. Orwoll

ES, Scheele

 WH,

 Paul S,

 Adami S,

 Syversen U,

 Hash sign-Perez

al. The effect of teriparatide [human parathyroid hormone glands (134)] therapy on bone density in men with osteoporosis. In Costa Miner Res. 2003; 18:917. 31. LaCroix I

 ,

M. Ott, Itikava

 ,

 L, Scholes

 D,

 Barlow WE. Low dose hydrochlorothiazide and preservation of bone mineral density in elderly men: a randomized, double-blind, placebo-controlled study. Ann internal Med. 2000, 133:51626. 32. Kannus

�

 Parkkari J, Niyemi

 S, Pasanen

 M,

 Palvanen M,

 Jarvinen M

 al. Preventing hip fractures in elderly people with hip protector. N Engl J Med. 2000, 343:150613. .